Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Hübel

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|March 25, 2022
Lymphoma: New Diagnosis and Current Treatment StrategiesKai Hübel
Oncology Research and Treatment|March 9, 2017
HIV-Associated MalignanciesKai Hübel
Current Oncology Reports|August 9, 2021
Correction to: The Changing Landscape of Lymphoma Associated with HIV InfectionKai Hübel
Blood|April 25, 2024
A promising step for high-risk FLKai Hübel
Expert Opinion on Pharmacotherapy|October 2, 2018
An evaluation of pixantrone for the treatment of non-Hodgkin's lymphomaKai Hübel
Current Oncology Reports|August 18, 2020
The Changing Landscape of Lymphoma Associated with HIV InfectionKai Hübel
Oncology and Therapy|March 21, 2024
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case ExampleKai Hübel
European Journal of Cancer (Oxford, England : 1990)|September 20, 2020
Biosimilars in oncology: Effects on economy and therapeutic innovationsKai Hübel, Florian Kron, Michael Patrick Lux
The Journal of Infectious Diseases|May 7, 2002
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gammaKai Hübel, David C Dale, W Conrad Liles
European Journal of Haematology|April 18, 2018
Malignant lymphoma in the HIV-positive patientAnne Meister, Marcus Hentrich, Christoph Wyen, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|March 25, 2022
Lymphoma: New Diagnosis and Current Treatment StrategiesKai Hübel
Oncology Research and Treatment|March 9, 2017
HIV-Associated MalignanciesKai Hübel
Current Oncology Reports|August 9, 2021
Correction to: The Changing Landscape of Lymphoma Associated with HIV InfectionKai Hübel
Blood|April 25, 2024
A promising step for high-risk FLKai Hübel
Expert Opinion on Pharmacotherapy|October 2, 2018
An evaluation of pixantrone for the treatment of non-Hodgkin's lymphomaKai Hübel
Current Oncology Reports|August 18, 2020
The Changing Landscape of Lymphoma Associated with HIV InfectionKai Hübel
Oncology and Therapy|March 21, 2024
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case ExampleKai Hübel
European Journal of Cancer (Oxford, England : 1990)|September 20, 2020
Biosimilars in oncology: Effects on economy and therapeutic innovationsKai Hübel, Florian Kron, Michael Patrick Lux
The Journal of Infectious Diseases|May 7, 2002
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gammaKai Hübel, David C Dale, W Conrad Liles
European Journal of Haematology|April 18, 2018
Malignant lymphoma in the HIV-positive patientAnne Meister, Marcus Hentrich, Christoph Wyen, et al.
Pageof 6